Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02562040 · ClinicalTrials.gov registry record · NA

Pediatric Adenotonsillectomy Trial for Snoring

A NA study, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
459
Enrollment target

NCT02562040 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 459 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02562040, a NA study, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
459 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the effects of early adenotonsillectomy (eAT) on the behavior, sleep-disordered breathing symptoms and quality of life for children who snore, but do not have obstructive sleep apnea, as well as identify factors that moderate responses to the surgery. Half of participants will receive eAT, while the other half will be observed with watchful waiting and supportive care.

Interventions

  • PROCEDURE Early Adenotonsillectomy (eAT)
  • BEHAVIORAL Watchful Waiting with Supportive Care (WWSC)

Trial Details

FieldValue
Enrollment Target 459 participants
Start Date 2017-06-06
Est. Completion 2022-02-28
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT02562040

The ClinicalTrials.gov registry entry for NCT02562040 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 459 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Early Adenotonsillectomy (eAT) is the first listed.

NCT02562040 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02562040 about?

NCT02562040 is a clinical study titled "Pediatric Adenotonsillectomy Trial for Snoring". The purpose of this study is to evaluate the effects of early adenotonsillectomy (eAT) on the behavior, sleep-disordered breathing symptoms and quality of life for children who snore, but do not have obstructive sleep apnea, as well as identify factors that moderate responses to the surgery. Half of...

What is the current status of trial NCT02562040?

This trial is currently completed. It is a NA study. The enrollment target is 459 participants. The study started on 2017-06-06. Estimated completion is 2022-02-28.

What interventions are being tested in trial NCT02562040?

The interventions under investigation include: Early Adenotonsillectomy (eAT) (PROCEDURE), Watchful Waiting with Supportive Care (WWSC) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02562040?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.